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Teng).MiR-17-92 cluster miRNAs are disclosed to contribute to the development of multiple organs and
tumorigenesis, but their roles in pancreas development remains unclear. In this study, we found
that miR-19b, a member of miR-17-92, was highly expressed in the pancreatic progenitor cells,
and miR-19b could target the 30 UTR of NeuroD1 mRNA to decrease its protein and mRNA levels.
Functional analysis showed that miR-19b exerted little effect on the proliferation of pancreatic pro-
genitors, whereas it inhibited the expression of insulin 1, but not insulin 2 in MIN6 cells. These
results suggest that miR-19b can downregulate insulin 1 expression through targeting transcription
factor NeuroD1, and thus regulate the differentiation and function of b-cells.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Pancreatic islet is comprised of endocrine cells, which control
multiple homeostatic functions. b-cell, the predominant islet cell
type, responds to glucose by synthesizing and secreting insulin,
thus maintains physiological glucose homeostasis [1,2]. Functional
disturbance of b-cells and insufﬁcient insulin secretion lead to dia-
betes [3,4]. During the development of mouse pancreas, endocrine
cells occur from e13.5 to e15.5, a stage termed the ‘‘secondary
transition’’ [5]. In this stage, the proliferation of pancreatic progen-
itor cells steps down, and their differentiation into endocrine cells,
particularly b-cells, increases rapidly [5]. It has been demonstrated
that the proliferation and differentiation of pancreatic progenitor
cells involve a cascade of inhibition and activation of speciﬁc
transcription factors, such as pancreatic and duodenal homeobox
factor-1 (Pdx-1), Neurogenin 3 (Ngn3) and Neurogenic differentia-
tion factor 1 (NeuroD1) [6].
In recent years, several studies have shown that microRNAs
(miRNAs), a class of non-coding RNAs, contribute to pancreatic
endocrine development. In Dicer (an essential enzyme for miRNAs
formation) null mutation mice, the blockage of miRNAs formationchemical Societies. Published by E
Road, Harbin 150040, China.
unboteng@nefu.edu.cn (C.-B.led to gross defects in all pancreatic lineages, and the differentia-
tion of endocrine cells especially the insulin-producing b-cells,
was inhibited [7,8]. MiR-375 was found to be involved in regulat-
ing insulin secretion andmaintaining a and b cell mass [9,10]. MiR-
15, miR-16 and miR-195 were reported to target Ngn3 in the
regenerating pancreas [11], and miR-124a could repress Foxa2
expression in MIN6 cells [12]. However, the function of miRNAs
in the proliferation or differentiation of pancreatic progenitor cells
is largely unknown.
It has been reported that the miR-17-92 cluster, which encodes
miR-17-5p, miR-18a, miR-19a, miR-20a, miR-19b andmiR-92, con-
tributes to the development of heart, lung, blood vessel or immune
system, and plays an important role in tumorigenesis [13–16].
MiR-19b, a key oncogenic component of miR-17-92 [17], was
found to regulate cell cycle progression by negatively regulating
tumor suppressor Pten and pro-apoptotic protein Bim to induce
lymphomas [17–19]. In the present study, we explored the func-
tion of miR-19b in the b-cell proliferation and differentiation.
2. Materials and methods
2.1. Experimental animals
Outbred strain CD1 mice were obtained from Beijing Laboratory
Animals Research Centre, and kept in compliance with thelsevier B.V. All rights reserved.
Fig. 1. Expression pattern of miR-19b during mouse pancreatic development. (A) The expression of mature miR-19b in e12.5, e15.5, e17.5 and adult pancreata were
determined by qRT-PCR, the mixed samples of e12.5 pancreata (550), e15.5 pancreata (150), e17.5 pancreata (5), and an adult mouse pancreas have been analyzed in the test.
The expression of miR-19b in adult pancreata was deﬁned as 1 and the Y-axis represented relative expression levels of miR-19b compared with adult pancreata. Expression of
miR-19b was normalized to U6. (B) qRT-PCR detected the relative levels of miR-19b in pancreatic progenitor cells, pancreatic islets and MIN6 cells. Expression of miR-19b was
normalized to U6.
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Committee of Northeast Forestry University.
2.2. Cell culture
3T3 and 293GP cells were maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) containing 25 mmol/l glucose supple-
mented with 10% heat-inactivated fetal bovine serum (FBS). The
MIN6 insulinoma cell line was a kind gift of Yiming Mu (General
Hospital of PLA, China), it was maintained in DMEM containing
25 mmol/l glucose supplemented with 15% FBS and 50 lmol/l 2-
mercaptoethanol (Sigma-Aldrich).
2.3. MiR-19b target gene prediction
MiR-19b target genes were predicted by the PicTar miRNA tar-
get gene prediction website (http://pictar.mdc-berlin.de/) and the
TargetScan algorithm from TargetScan Version 5.1 (http://
www.targetscan.org/).
2.4. DNA construct
A 417-bp fragment from the 30 untranslated region (30 UTR) of
NeuroD1 (position 1777–2193, NM_010894) containing the pre-
dicted miR-19b binding sites was cloned into the XbaI and FseI
sites of pGL3 control vector. The corresponding mutant constructs
were created by mutating the seed region of the miR-19b binding
sites. To construct enhanced green ﬂuorescent protein-NeuroD1
(EGFP-NeuroD1) fusion protein, the full length of NeuroD1 which
contains coding sequence and 30 UTR, but without start codon,
was inserted into the XhoI and EcoRI sites of pEGFP-C1 vector.
All constructs were conﬁrmed by DNA sequencing.
2.5. Cells transfection
Mimic miRNA, miRNA inhibitor (20O-Me modiﬁed antisense oli-
gonucleotide) (GenePharma) and plasmids were transfected into
MIN6, 293GP, 3T3 or pancreatic progenitor cells using Lipofect-
amine 2000 (Invitrogen). 80 nmol/l (ﬁnal concentration) mimic
miRNA or miRNA inhibitor was transfected into MIN6 cells, total
RNA was isolated for real time quantitative PCR (qRT-PCR) 48 h
after transfection, immunoﬂuorescent staining of insulin and
western blot analysis of NeuroD1 were performed 72 h after
transfection. 300 ng pEGFP-C1-NeuroD1, 60 nmol/l (ﬁnal concen-
tration) mimic miRNA and 120 nmol/l (ﬁnal concentration) miRNAinhibitor were co-transfected into 293GP or 3T3 cells, NeuroD1
mRNA or protein expression was measured at 48 h or 72 h after
transfection, respectively. For cell proliferation assay, 80 nmol/l (ﬁ-
nal concentration) mimic miRNA was transfected into MIN6 cells
or pancreatic progenitor cells.
2.6. Dual luciferase reporter assay
3T3 cells were plated into 24-well plates 24 h before transfec-
tion, 200 ng pGL3-control containing the wild type or mutated
NeuroD1 30 UTRs, 50 ng pRL-TK and 30 nmol/l mimic miRNAs were
co-transfected into 3T3 cells by using Lipofectamine 2000. Relative
ﬁreﬂy luciferase activity (normalized to Renilla luciferase activity)
was measured 24 h after transfection by the Dual-Luciferase Re-
porter Assay Kit (Promega) on GloMaxTM 20/20 Luminometer
(Promega).
2.7. RT-PCR and qRT-PCR
Total RNAs were isolated by using TRIzol reagent (Invitrogen) or
RNAprep Micro Kit (Tiangen, Beijing), then treated with DNase I
(RNase free) (Takara). To detect miRNA expression, total RNAs
were polyadenylated with ATP by Escherichia coli poly (A) polymer-
ase (Biolabs, New England). The polyadenylated total RNAs were
reverse transcribed with M-MLV Reverse Transcription Reagents
(Invitrogen) and a poly (T) primer ligated with a adapter for miRNA
quantitative assays. The RNAs without polyadenylation were re-
verse transcribed with oligod (T) for mRNA assay.
qRT-PCR was performed using the ABI 7500 sequence detection
system (Applied Biosystems). U6 small nuclear RNA was used as an
endogenous control for miRNAs and b-actin was used for mRNAs.
All reactions were run in triplicate and included no template con-
trols for each gene. The relative amount of each mRNA to b-actin or
miRNA to U6 RNA was calculated using the 2DDCT method. The le-
vel of signiﬁcance was determined by one-way analysis of variance
(ANOVA) with SPSS Statistics 17.0. All quantitative data presented
were the mean ± SEM. Sequences of primers used for RT-PCR and
qRT-PCR in this study were as described in Supplementary Table 1.
2.8. Western blotting analysis
Cellular total proteins were extracted with cell lysis buffer.
Protein extracts were then centrifuged at 12 000g for 5 min at
4 C and the supernatants were used for the experiments. Proteins
were separated on 10% SDS–PAGE gels and electroblotted onto a
Fig. 2. Identiﬁcation of NeuroD1 as the target gene of miR-19b. (A) A schematic
representation of the pGL3-luciferase reporter constructs used in this study. (B)
Location and sequences of the three miR-19b target sites (nominated here as 1, 2
and 3) in the NeuroD1 30 UTR; the sequence of mouse miR-19b is indicated,
alongside the mutations introduced in the different target sites (underlined
nucleotides) for generating mutated reporter constructs. (C) Luciferase activity
was determined 24 h after transfection. All luciferase values were normalized to
Renilla luciferase. Single and double stars indicate P < 0.05 and P < 0.01,
respectively.
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NeuroD1 (Santa Cruz) and anti-b-actin (Biosynthesis). The bands
were quantiﬁed using the ImageJ 1.42 software after densitometric
scanning of the ﬁlms.
2.9. Immunoﬂuorescent staining
Cells were ﬁxed in 4% fresh paraformaldehyde for 30 min fol-
lowed by permeabilization using 0.3% triton X-100 for 30 min.
After blocking for 1 h, cells were incubated in primary antibody
rabbit anti-insulin (1:100, Santa Cruz), goat anti-c-peptide
(1:100, Linco), rabbit anti-glucagon (1:200, Zymed) or rabbit
anti-somatostatin (1:500, DAKO) overnight at 4 C. Incubation with
secondary antibody FITC-conjugated IgG (1:150, Jackson Immuno-
research) or Rhodamine-conjugated IgG (1:150, Jackson Immuno-
research) was conducted for 1 h. Images were acquired using a
ﬂuorescent microscope equipped with a cooled three-chip
charge-coupled-device camera (Carl Zeiss).
2.10. Cell proliferation assay
MIN6 and pancreatic progenitor cells proliferation were deter-
mined by CCK-8 assay and bromodeoxyuridine (BrdU) incorpora-
tion assay. For CCK-8 (Dojindo Molecular Technologies) assay,
cells were incubated in CCK-8 solution for 2 h at 37 C. The amount
of formazan dye was measured by absorbance at 450 nm with a
microplate reader. For the BrdU incorporation assay, 10 lmol/l
BrdU was ﬁrst added into the culture medium for 1 h, and then
cells were ﬁxed, acid-treated and followed by immunostaining
analysis with BrdU antibody (Sigma) and HRP-conjugated second-
ary antibody (Biosynthesis). BrdU incorporation was observed un-
der a light microscope. At least 2000 cells were counted for each
sample.
2.11. Isolation of adult pancreatic progenitor cells and islets
The adult pancreatic progenitor cells were screened as the
following procedure. Pancreata from 4–6-week-old mice were
minced into 8-mm3 fragments to perform the digestion with type
IV collagenase (Invitrogen) at 37 C for 20 min. Single cells were
collected and seeded at a density of 1.5  104 cells/cm2 in
proliferating media (DMEM/F12 medium containing 2% FBS and
supplemented with 1  B27 (Invitrogen), 2 ng/ml EGF (R&D), 10
ug/ml insulin (Sigma-Aldrich) and 50 lmol/l 2-mercaptoethanol).
The ﬁbroblasts were removed through deserting the attached cells
after seeding for 40 min, the epithelial cells attached at a low den-
sity (<300 cells per square cm). 7–10 days after culturing, single-
clone epithelial cells were picked out for detection, or to subculture
for cell proliferation assays. Islet isolation was conducted as re-
ported by Gotoh, M. et al [20].
3. Results
3.1. Expression pattern of miR-19b in the developing mouse pancreas
At e12.5, the mouse pancreatic bud is composed of a common
pool of multipotent progenitor cells, while at e15.5, most of
progenitor cells begin to differentiate toward endocrine and exo-
crine cell lineages [5,21]. To determine which miRNAs partici-
pate in the proliferation and differentiation of pancreatic
progenitors, we carried out qRT-PCR assays at four distinct
developmental stages: e12.5, e15.5, e17.5 and adult (6 weeks
old). The results showed that the expression of miR-19b was
highest at e12.5, but lowest at e15.5, comparing with the other
stages (Fig. 1A).To further explore the expression of miR-19b in pancreatic pro-
genitor cells, we isolated a population of epithelia-morphological
cells with colony-forming capability from adult mouse pancreata.
RT-PCR analysis showed that these cells did not express endocrine
markers insulin 1, insulin 2, glucagon, somatostatin, and pancreatic
polypeptide or the exocrine markers amylase 2 and elastase 1, but
expressed pancreas speciﬁc transcription factor-1a (ptf1a), c-Met,
CD133, and Hes1 (Fig. S1A), which are candidate molecular markers
of pancreatic progenitor cells [22–24]. The differentiation potential
of these cells was analyzed by culturing them under the endocrine
differentiation condition. After inducing the cells for 15 days, Pdx1,
Ngn3, NeuroD, Nkx2.2, Nkx6.1, Pax6, and glucose transporter 2
(Glut2) were detected by RT-PCR (Fig. S1B). In addition, the endo-
crine hormone genes insulin, glucagon and somatostatin were
expressed, but pancreatic polypeptide mRNA was not detected
(Fig. S1B). Immunoﬂuorescent staining results showed that
Fig. 3. Overexpression of miR-19b reduced NeuroD1 protein and mRNA in vitro. 3T3 cells were co-transfected with pEGFP-C1-NeuroD1, mimic miRNA and/or miRNA
inhibitor. 48 h after transfection, RNA was extracted and the overexpression of miR-19b was measured by qRT-PCR, expression of miR-19b was normalized to U6 (A); the
expression of NeuroD1 mRNA was analyzed by qRT-PCR, expression of NeuroD1 was normalized to b-actin (B); 72 h after transfection, EGFP-NeuroD1 fusion protein
expression in 3T3 cells was analyzed under a ﬂuorescence microscope (C) (100); The total proteins were obtained from the lysis cells and the expression of NeuroD1 was
analyzed by western blotting, expression ratio represented relative expression levels of NeuroD1 in group r compared with s or u compared with t, expression of
NeuroD1 in group s or t was deﬁned as 1, respectively (D).
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cells could be detected among the differentiated cells (Fig. S1C).
The results indicated that these cells are pancreatic progenitor
cells. The expression of miR-19b in the isolated pancreatic progen-
itor cells, islets and MIN6 cells was assessed by qRT-PCR. The result
showed that the expression of miR-19b was higher in the pancre-
atic progenitors than the pancreatic islets and MIN6 cells (Fig. 1B).
3.2. Analysis of the target genes for miR-19b
We searched for the potential target genes of miR-19b by PicTar
[25] and Targetscan [26], and focused on the genes known to be in-
volved in the differentiation of b-cells. Our immediate attention
was drawn to NeuroD1, a transcription factor that regulates the
differentiation of pancreatic progenitor cells into b-cells and plays
an essential role in maintaining normal b-cells function [27].
After comparing the results given by the two miRNA prediction
programs, we found that miR-19b has three target sites in the
NeuroD1 mRNA 30 UTR (Fig. 2A), which are highly conserved in
vertebrate. To test the effect of miR-19b on the NeuroD1 expres-
sion, a fragment of NeuroD1 30 UTR containing the three putative
target sites was cloned into the downstream of the ﬁreﬂy luciferase
stop codon of pGL3 control expression vector. After the recombi-
nant vector was co-transfected with synthetic miR-19b into 3T3
cells, the luciferase activity was signiﬁcantly inhibited than that
co-transfected with the control miRNA (Fig. 2C).
Then we mutated the targeting sites of NeuroD1 30 UTR in the
pGL3-control vector (Fig. 2B). Mutational analysis showed that
the ﬁrst and second site in the fragment were important inmediating the inhibition of miR-19b (Fig. 2C). When the ﬁrst site
was mutated, luciferase activity was less efﬁciently repressed by
miR-19b than that in the wild-type construct. This result indicates
that the ﬁrst site is functional. In addition, the mutation of the sec-
ond site also modiﬁed miR-19b-induced repression of luciferase,
which indicates that the second site is also necessary for miR-
19b activity. However, the mutation of the third site did not rescue
the luciferase activity. Furthermore, when the ﬁrst site and the sec-
ond site were both mutated, the rescue of luciferase activity was
stronger than either mutation of them, these results demonstrate
that the two target sites exert cooperative functions.
3.3. miR-19b inhibited the expression of NeuroD1 at both mRNA and
protein level
In order to validate whether miR-19b is capable of regulating
NeuroD1 expression, we cloned the DNA sequence corresponding
to the entire NeuroD1 mRNA into pEGFP-C1 to construct EGFP-
NeuroD1 fusion protein expression vector (pEGFP-C1-NeuroD1),
then the vector was co-transfected with either synthesized miR-
19b or miR-19b inhibitor into 3T3 cells. The overexpression of
miR-19b was conﬁrmed by qRT-PCR (Fig. 3A). Also, qRT-PCR results
showed that overexpression of miR-19b decreased NeuroD1mRNA
level (Fig. 3B). Western blotting results showed that the NeuroD1
protein was signiﬁcantly inhibited by miR-19b (Fig. 3D). Mean-
while, the expression of EGFP protein was repressed because of
the reducing NeuroD1 (Fig. 3C). Similar results were observed in
293GP cells which were co-transfected with pEGFP-C1-NeuroD1,
miR-19b and/or miR-19b inhibitor (Fig. S3).
Fig. 4. Overexpression of miR-19b had no effect on pancreatic cells proliferation. (A) MIN6 or pancreatic progenitor cells were transfected with miR-19b or control miRNA.
72 h after transfection, cells proliferation was evaluated by CCK-8 assay; (B) MIN6 cells proliferation was further conﬁrmed by BrdU incorporation assay.
Fig. 5. Effect of miR-19b repressed NeuroD1 and insulin 1 expression in MIN6 cells. MIN6 cells were transfected with mimic miRNA or miRNA inhibitor, (A) 72 h after
transfection, the cells were homogenized and the expression of NeuroD1 was analyzed by western blotting, expression ratio represented relative expression levels of
NeuroD1 in groups compared withr ort compared withu, expression of NeuroD1 in groupr ort was deﬁned as 1, respectively. (B) 48 h after transfection, NeuroD1,
insulin 1 and insulin 2 mRNA levels were measured by qRT-PCR; (C) 72 h after transfection, cells were ﬁxed and insulin content (green) was detected by immunostaining
(200). (D) MIN6 insulin 1 and insulin 2 mRNA levels were measure by qRT-PCR. Expression of mRNA was normalized to b-actin. Double stars indicate P < 0.01.
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and pancreatic progenitor cells
Previous studies indicated that miR-17-92 promoted lung
epithelial progenitor cells and leukemia stem cells proliferation
[15,28]. Here we explore whether miR-19b can inﬂuence the
proliferation of pancreatic cells. To address this question,
miR-19b or control miRNA was transfected into pancreatic progen-
itor or MIN6 cells. Overexpression of miR-19b was conﬁrmed by
qRT-PCR (Fig. S2). CCK8-assay results showed that the proliferation
of pancreatic progenitor cells or MIN6 was not interfered signiﬁ-
cantly by miR-19b (Fig. 4A). Also, BrdU incorporation study con-
ﬁrmed that miR-19b could hardly inﬂuence MIN6 cells
proliferation (Fig. 4B).3.5. miR-19b decreased insulin 1 expression via negative regulation of
NeuroD1
After miR-19b was overexpressed in MIN6 cells, it was found
that the endogenous NeuroD1 protein was reduced, while inhibi-
tion of the endogenous miR-19b has little effect on the expression
of NeuroD1 (Fig. 5A). Previous studies have shown that NeuroD1 is
a crucial factor for insulin gene transcription [29,30]. To test
whether miR-19b can inhibit insulin transcription by negatively
regulating NeuroD1, miR-19b or control miRNA was transfected
into insulin-producing MIN6 cells, then the expression of NeuroD1,
insulin 1 and insulin 2 mRNAs were measured by qRT-PCR. The re-
sults showed that the expression levels of NeuroD1 and insulin 1
mRNA were reduced by miR-19b, whereas insulin 2 transcripts
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(Fig. 5B). Moreover, the total insulin protein was not signiﬁcantly
reduced by immunoﬂuoresent analysis (Fig. 5C), since the expres-
sion of insulin 2 mRNA was about 9 times more than that of insulin
1 mRNA in MIN6 cells (Fig. 5D).
4. Discussion
In this study, we have found that miR-19b is highly expressed in
the developing pancreas and adult pancreatic progenitor cells, but
not in the differentiated cells. MiR-17-92 has been reported to pro-
mote lung epithelial progenitor cells and leukemia stem cells pro-
liferation [15,28]. However, our results show that miR-19b exerts
little effects on the proliferation of both MIN6 and pancreatic pro-
genitor cells. This result is consistent with previous studies that
overexpression of miR-19 does not enhance cell proliferation but
reduces apoptosis in lymphoma [17,19].
Through bioinformatics prediction and experimental assays, we
have noticed that NeuroD1 is a target gene of miR-19b. NeuroD1 as
one of downstream genes of endocrine progenitor maker Ngn3, a
key transcription factor in regulating differentiation of endocrine
cells, plays an important role in endocrine development [31,32].
NeuroD1 null mice died postnatally from severe diabetes due to
a dramatic loss of insulin-producing b-cells, moreover, the number
of glucagon-producing a-cells and somatostatin-producing d-cells
were reduced modestly [27]. In this study, we showed that miR-
19b could target the 30 UTR sequence of NeuroD1 mRNA to inhibit
its expression, combined with that miR-19b was expressed highly
in pancreatic progenitor cells, lowly in pancreatic islets and MIN6
cells, these results indicate that miR-19b involves in the regulation
of pancreatic endocrine differentiation from progenitor cells.
Although overexpression of miR-19b repressed the level of Neu-
roD1 mRNA and protein, transfection of miR-19b inhibitor into
MIN6 cells did not increase the level of NeuroD1, this may cause
by the low level of miR-19b in MIN6 cells (Fig. 1B). On the other
hand, it has been reported that multiple miRNAs bind the same tar-
get mRNA, they act cooperatively to reduce mRNA translation by
more than the sum of their individual effects [33]. When predicting
the miRNAs which can regulate NeuroD1 using bioinformation
softwares, we found that NeuroD1 was the potential target of 64
miRNAs using Targetscan (http://www.targetscan.org/), or 44 miR-
NAs using PicTar (http://pictar.mdc-berlin.de/). Otherwise, it has
been conﬁrmed that NeuroD1 is the target gene of miR-124 in neu-
ral cells [34], and miR-124 is highly expressed in MIN6 cells [9].
Thus, miR-19b, miR-124 and other miRNAs might act combinatori-
ally NeuroD1 in MIN6 cells.
Several previous in vitro studies have shown that NeuroD1 is
capable of activating both insulin 1 and insulin 2 through binding
their conserved E box elements to function as an important tran-
scription factor in pancreatic b-cell differentiation and mature b-
cell function [31,35,36]. In this study, overexpression of miR-19b
in MIN6 cells exactly reduced insulin 1 transcription, but insulin 2
transcription was not inﬂuenced. These results are consistent with
the published observation that insulin 1 was almost extinguished
and insulin 2 was unaffected in the mutant mice with b-cell-spe-
ciﬁc knockout of NeuroD1 [37]. The molecular mechanism of
miR-19b in regulating the expression of insulin genes should be
further explored by performing complementary in vitro and
in vivo studies.
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